Trial Profile
A Phase 2a Open-Label, Dose-ranging Study of the Safety and Tolerability of ATS907 in Subjects With Primary Open Angle Glaucoma and Ocular Hypertension
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 16 Apr 2014
Price :
$35
*
At a glance
- Drugs ATS 907 (Primary)
- Indications Ocular hypertension; Open-angle glaucoma
- Focus Adverse reactions
- Sponsors Altheos
- 16 Apr 2014 New trial record